News|Videos|January 26, 2024

‘Tis the Season: Making Sense of Influenza and COVID-19 This Year

The National Foundation for Infectious Diseases (NFID) medical director weighs in on this year’s respiratory virus season and offers some strategies to prevent transmission.

During this time of year in the northern hemisphere, influenza and COVID-19 are in full effect. As the season is hitting or near its peak, the general public will once again need to be aware of the viruses and will want to find strategies to avoid them.

Anecdotally, people are saying the current COVID-19 variant is not as significant or severe as previous strains. However, there is great variability in what the experience of being sick is depending on people’s ages, existing comorbidities, and overall health profile. So, COVID-19 can look different to different people. Whereas, a young person who is in good health may see symptoms that mirror a cold; but a middle-aged person or a senior might see more severe symptoms that feel like influenza.

Still, this does not downplay the need for preventative care for everyone, especially in the form of vaccines, explained Robert H. Hopkins Jr, MD, medical director, NFID; professor of Internal Medicine and Pediatrics and chief, Division of General Internal Medicine, University of Arkansas for Medical Sciences.

“For those who still haven't gotten their COVID-19 [vaccine], their influenza vaccine, and those eligible to get RSV vaccination, please do that. It is not too late,” Hopkins said. “It does take a little time for you to develop vaccine protection. But, I would encourage people to get that done because we don't have a good way of predicting, even if you've had COVID-19 or flu earlier in the season, that you're not going to get it again.”

Additionally, Hopkins discusses hygiene and risk mitigation as nonspecific interventions for prevention. These are things we may be aware of in some capacity but serve as good reminders.

“Washing your hands is important. Second, if you're going to be out in in crowded situations, I would encourage people to wear a mask...a mask is not perfect, but if you're wearing a mask over your nose and mouth, you're reducing the number of particulates,” stated Hopkins.

He also reminds people to cough and sneeze into the sleeves of their shirts as opposed to their hands. This can prevent transmission of germs. And lastly, Hopkins talks about going out into crowds.

“If you have an opportunity to get out in a crowded setting, think a little bit about what your risk tolerance is for that setting. If you're somebody that's immune compromised, if you have significant health conditions, maybe this is not the time to be going to a concert, or to a basketball game, or to a crowded event where we may be more likely to catch one of these illnesses.

For those who might be vaccine averse, and do not like the idea of getting 2 vaccines at the start of every seasonal virus year, there are influenza/COVID-19 combination vaccines in development. Moderna has previously stated it was targeting a potential regulatory approval for their combination vaccine in 2025.

Contagion spoke to Hopkins who offered some insights on this year’s COVID and influenza seasons, combination vaccines, and isolation considerations for those who have the flu or COVID-19.


Related to this article

GSK's mRNA Influenza Vaccine Moves to Phase 3 Trial
GSK will advance its investigational mRNA seasonal flu vaccine candidate, which targets both hemagglutinin and neuraminidase, into a phase 3 trial in September 2026 after the shot outperformed licensed flu vaccines in a phase 2 study.
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.
REMAP-CAP and the Tamiflu “Pre-Release”: A Set-Up for Disaster
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.
Drawing Borders Around a Borderless Specialty
Editor in chief Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, discusses the proposed OMB rule restricting federal grants for international research collaboration, and how it threatens infectious disease medicine's inherently borderless surveillance networks, publication access, and knowledge-sharing systems.